Estimation of The Health Benefit Associated With A Potential Denosumab-Induced Extension of Progression Free Survival In Multiple Myeloma Patients

The objective of this study was to quantify the potential incremental health benefit associated with a Denosumab-induced extension of PFS, in MM patients.
Source: Value in Health - Category: International Medicine & Public Health Authors: Source Type: research
More News: Myeloma | Reclast | Study | Xgeva | Zometa